Predicting the risk of venous thromboembolism recurrence.

@article{Heit2012PredictingTR,
  title={Predicting the risk of venous thromboembolism recurrence.},
  author={John A Heit},
  journal={American journal of hematology},
  year={2012},
  volume={87 Suppl 1},
  pages={S63-7}
}
Venous thromboembolism (VTE) is a chronic disease with a 30% ten-year recurrence rate. The highest incidence of recurrence is in the first 6 months. Active cancer significantly increases the hazard of early recurrence, and the proportions of time on standard heparin with an APTT ≥ 0.2 anti-X(a) U/mL, and on warfarin with an INR ≥ 2.0, significantly reduce the hazard. The acute treatment duration does not affect recurrence risk after treatment is stopped. Independent predictors of late… CONTINUE READING